Acquiring Company
PAI Pharma
Acquired Company
Nexus Pharmaceuticals
GreenvilleIllinoisManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CareMedicalDescription
PAI Pharma has acquired Nexus Pharmaceuticals to expand its portfolio of sterile injectable products. This acquisition enhances PAI's presence in the hospital market with a broader range of critical care medicines.
Other recent acquisitions in Pharmaceutical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Globus Medical acquires Synaptive Medical (November 3, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- BPL Medical Technologies acquires Medec for growth (October 14, 2026)
Who to call at PAI Pharma, and when
When PAI Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day PAI Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PAI Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PAI Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PAI Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nexus Pharmaceuticals?
Nexus Pharmaceuticals was acquired by PAI Pharma, based in Greenville. The deal was reported on November 12, 2026. PAI Pharma is privately held and operates in Manufacturing.
When did PAI Pharma acquire Nexus Pharmaceuticals?
PAI Pharma's acquisition of Nexus Pharmaceuticals was reported on November 12, 2026. PAI Pharma has acquired Nexus Pharmaceuticals to expand its portfolio of sterile injectable products. This acquisition enhances PAI's presence in the hospital market with a broader range of critical care medicines. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nexus Pharmaceuticals do?
Nexus Pharmaceuticals, LLC is a US-based healthcare company specializing in innovative processes to manufacture specialty and generic drugs. It is privately held, operating in Manufacturing, and is based in Illinois.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.